Condition

Secondary Sclerosing Cholangitis (4)

COVID-19 (1)

Primary Biliary Cholangitis (1)

Primary Sclerosing Cholangitis (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Unknown status (1)

Phase

n/a (1)

phase 3 (1)

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Hannover Medical School (1)

Medical University of Graz (1)

University Hospital Tuebingen (1)

Intervention

bezafibrate (1)

control of liver enzymes (1)

endoscopic retrograde cholangiography (erc) (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

other (1)

procedure (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

secondary sclerosing cholangitis

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Secondary Sclerosing Cholangitis Trial (Endoscopic retrograde cholangiography (ERC))

Not yet recruiting

Secondary Sclerosing Cholangitis

Endoscopic retrograde cholangiography (ERC)

(no location specified)

May 25, 2022

Secondary Sclerosing Cholangitis in Critically Ill Patients

Active, not recruiting

Secondary Sclerosing Cholangitis

Graz, Austria

Department of Internal Medicine, Medical University of Graz

Mar 16, 2022

SSC-COVID in Patients After COVID-19

Completed

Secondary Sclerosing Cholangitis
COVID-19

control of liver enzymes

Tuebingen, Germany

University Hospital of Tuebingen

Feb 9, 2022

Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Secondary Sclerosing Cholangitis Trial in Netherlands, Spain

Unknown status

Primary Biliary Cholangitis
+2 more

Bezafibrate
Placebo

Amsterdam, Netherlands
+8 more

Mar 4, 2016